These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 16051194)
1. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638 [TBL] [Abstract][Full Text] [Related]
3. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling. Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967 [TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells. Mlejnek P; Dolezel P; Kosztyu P J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073 [TBL] [Abstract][Full Text] [Related]
5. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells. Kim GD; Oh J; Jeong LS; Lee SK Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876 [TBL] [Abstract][Full Text] [Related]
6. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189 [TBL] [Abstract][Full Text] [Related]
7. Cl-IB-MECA inhibits human erythropoiesis. Bhanu NV; Aerbajinai W; Gantt NM; Jackson EK; Goh SH; Terry Lee Y; Miller JL Br J Haematol; 2007 May; 137(3):233-6. PubMed ID: 17408462 [TBL] [Abstract][Full Text] [Related]
8. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
9. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells. Kim TH; Kim YK; Woo JS Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643 [TBL] [Abstract][Full Text] [Related]
10. A3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells. Kim H; Kang JW; Lee S; Choi WJ; Jeong LS; Yang Y; Hong JT; Yoon DY Anticancer Res; 2010 Jul; 30(7):2823-30. PubMed ID: 20683018 [TBL] [Abstract][Full Text] [Related]
11. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Kim SG; Ravi G; Hoffmann C; Jung YJ; Kim M; Chen A; Jacobson KA Biochem Pharmacol; 2002 Mar; 63(5):871-80. PubMed ID: 11911839 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. Mlejnek P; Dolezel P Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715 [TBL] [Abstract][Full Text] [Related]
14. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation. Lu J; Pierron A; Ravid K Cancer Res; 2003 Oct; 63(19):6413-23. PubMed ID: 14559831 [TBL] [Abstract][Full Text] [Related]
15. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688 [TBL] [Abstract][Full Text] [Related]
16. A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines. Joshaghani HR; Jafari SM; Aghaei M; Panjehpour M; Abedi H J Cancer Res Ther; 2017; 13(1):107-112. PubMed ID: 28508842 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway. Aghaei M; Panjehpour M; Karami-Tehrani F; Salami S J Cancer Res Clin Oncol; 2011 Oct; 137(10):1511-23. PubMed ID: 21830157 [TBL] [Abstract][Full Text] [Related]
18. Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells. Pepe S; Tortora G; Noguchi PD; Marti GE; Washington GC; Cho-Chung YS Cancer Res; 1991 Dec; 51(23 Pt 1):6263-7. PubMed ID: 1657383 [TBL] [Abstract][Full Text] [Related]
19. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166 [TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Shneyvays V; Jacobson KA; Li AH; Nawrath H; Zinman T; Isaac A; Shainberg A Exp Cell Res; 2000 May; 257(1):111-26. PubMed ID: 10854059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]